Celltrion Healthcare starts to sell ‘Herzuma’ in Europe

Celltrion Healthcare announced on the 3^rd that ‘Herzuma(generic name: trastuzumab),’ an antibody biosimilar for the treatment of breast cancer and stomach cancer, was first launched in the U.K. It is an early launch which was made only in 3 months of getting approval for Herzuma from the European Medicines Agency last February.

With the launch in the U.K., Celltiron Healthcare is planning to s...